Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sequenom Inc (NASDAQ:SQNM)

2.36
Delayed Data
As of Jul 29
 -0.01 / -0.42%
Today’s Change
0.82
Today|||52-Week Range
2.99
+43.90%
Year-to-Date
Can The Uptrend Continue for Sequenom (SQNM)?
Jul 29 / Zacks.com - Paid Partner Content
LabCorp (LH) Tops Q2 Earnings, View Up, to Buy Sequenom
Jul 27 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close2.37
Today’s open2.36
Day’s range2.36 - 2.37
Volume2,352,404
Average volume (3 months)1,363,296
Market cap$282.5M
Dividend yield--
Data as of 3:59pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)-9.37%
Earnings growth (this year)-0.32%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)-15.36%
P/E ratioNM
Price/Sales1.51
Price/Book--

Competitors

 Today’s
change
Today’s
% change
LMATLeMaitre Vascular In...+0.61+3.68%
ELOSSyneron Medical Ltd-0.03-0.41%
UTMDUtah Medical Product...-0.68-1.03%
TNDMTandem Diabetes Care...-1.15-14.78%
Data as of 3:59pm ET, 07/29/2016

Financials

Last reporting dateJuly 25, 2016
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$128.3M
Annual profit (last year)-$16.3M
Net profit margin-12.73%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Dirk van den Boom
Chief Financial Officer &
Senior Vice President
Carolyn D. Beaver
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs